{"brief_title": "Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058)", "brief_summary": "A 10-week study to compare the reduction in cholesterol following treatment with two different marketed drugs in patients with hypercholesterolemia.", "detailed_description": "The duration of treatment is 6 weeks.", "condition": "Hypercholesterolemia", "intervention_type": "Drug", "intervention_name": "Comparator: Rosuvastatin", "criteria": "Men and women aged 18 to 69 years, with elevated cholesterol levels may be eligible to participate in a research study to assess the efficacy and safety of two marketed drugs.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "69 Years", "healthy_volunteers": "No", "id": "NCT00090298.xml"}